Sunnybrook Health Sciences Centre

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1948-01-01

Employees: 10K

Market Cap: -

Website: http://www.sunnybrook.ca

Clinical Trials

Ruxolitinib in the Treatment of Chronic Lymphocytic Leukemia

Phase 1

Completed

Conditions: Chronic Lymphocytic Leukemia

Interventions: Drug: Ruxolitinib

First Posted Date: 2013-12-19

Last Posted Date: 2016-09-26

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 13

Registration Number: NCT02015208

Locations: 🇨🇦
Sunnybrook Odette Cancer Center, Toronto, Ontario, Canada

Post-stroke Triage "DOC": Simple Screening for Depression, Obstructive Sleep Apnea and Cognitive Impairment

Completed

Conditions: Transient Ischemic Attack
Stroke
Depression
Cognitive Impairment
Obstructive Sleep Apnea

First Posted Date: 2013-12-10

Last Posted Date: 2015-11-25

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 1504

Registration Number: NCT02007265

Locations: 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Early Prevention of Post Traumatic Stress Disorder

Not Applicable

Completed

Conditions: Post Traumatic Stress Disorder

Interventions: Behavioral: Intervention
Other: Treatment as usual

First Posted Date: 2013-12-09

Last Posted Date: 2016-08-10

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 99

Registration Number: NCT02004743

Locations: 🇨🇦
Sunnybrook Health Sciences Center, Toronto, Ontario, Canada

Ondissolve in the Prophylaxis/Rescue of Radiation Induced Nausea and Vomiting

Phase 2

Completed

Conditions: Nausea
Vomiting

Interventions: Drug: Ondansetron

First Posted Date: 2013-12-09

Last Posted Date: 2018-08-16

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 30

Registration Number: NCT02006056

Locations: 🇨🇦
Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Mental Health Telemetry for Self-Management in Major Depression

Not Applicable

Completed

Conditions: Major Depressive Disorder

Interventions: Device: MHT

First Posted Date: 2013-12-03

Last Posted Date: 2017-01-05

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 27

Registration Number: NCT01999010

Locations: 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

The Influence of CSRT-led Telephone Follow-up on ESAS Scores in Patients Who Have Been Treated With Lung SBRT

Not Applicable

Withdrawn

Conditions: Lung Cancer, Anxiety Post SBRT

Interventions: Other: CSRT led telephone follow up

First Posted Date: 2013-11-25

Last Posted Date: 2019-11-19

Lead Sponsor: Sunnybrook Health Sciences Centre

Registration Number: NCT01993901

Locations: 🇨🇦
Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada

Overlooked Population at Risk for AIN.

Not Applicable

Completed

Conditions: High Grade Cervical Dysplasia
Cervical Cancer

Interventions: Procedure: Screening Anal Pap Smear - With High Resolution Anoscopy
Procedure: Screening Anal Pap Smear - No High Resolution Anoscopy

First Posted Date: 2013-09-30

Last Posted Date: 2024-04-17

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 355

Registration Number: NCT01953094

Locations: 🇨🇦
Odette Cancer Centre, Toronto, Ontario, Canada

SABR Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN)

Phase 1

Conditions: Prostate Cancer

Interventions: Radiation: Stereotactic ablative radiotherapy

First Posted Date: 2013-09-30

Last Posted Date: 2020-11-24

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 30

Registration Number: NCT01953055

Locations: 🇨🇦
Odette Cancer Centre/Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders

Not Applicable

Withdrawn

Conditions: Obsessive-Compulsive Disorder
Anxiety Disorders

Interventions: Behavioral: Psychoeducation

First Posted Date: 2013-09-30

Last Posted Date: 2018-09-06

Lead Sponsor: Sunnybrook Health Sciences Centre

Registration Number: NCT01953042

Locations: 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.

Phase 4

Completed

Conditions: Ovarian Cancer
Anemia
Uterine Cancer
Cervical Cancer

Interventions: Other: Placebo
Other: Oral Ferrous Fumarate

First Posted Date: 2013-09-30

Last Posted Date: 2021-05-12

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 200

Registration Number: NCT01953107

Locations: 🇨🇦
Odette Cancer Centre, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy